🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationFDA March 2026 enforcement update — compounding pharmacies Page 6

FDA March 2026 enforcement update — compounding pharmacies

RegAffairsDC Fri, Dec 1, 2023 at 4:00 PM 275 replies 54,177 viewsPage 6 of 20
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Dec 2, 2023 at 12:30 AM#26

lisa_labSD — that is really helpful context on FDA March 2026. Follow-up question: did you change anything about your diet at the same time?

I am in a similar situation (month 2) and trying to set realistic expectations.

Last edited: Dec 2, 2023 at 2:30 AM
3 23PharmD_Rodriguez, julia.endo, JessicaM_2024
Reply Quote Save Share Report
fiona_VT
Member
178
890
Dec 2024
Vermont
Dec 2, 2023 at 12:47 AM#27

Want to share my personal experience related to FDA March 2026 enforcement since I think it might help others in a similar situation.

I started my GLP-1 journey in October 2024 at 252 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.

Now, 8 months later: I am down 77 lbs, my labs have normalized, and I am off 2 of my 3 medications. The FDA March 2026 aspect specifically was something that made a big difference in my journey.

This community helped me every step of the way.

21 24hans_munich, jason_sac26, chris_chi24 and 18 others
Reply Quote Save Share Report
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Dec 2, 2023 at 1:04 AM#28

lisa_labSD — that is really helpful context on FDA March 2026. Follow-up question: did you experience any side effects during this phase?

I am in a similar situation (about to start) and trying to set realistic expectations.

8 16PharmacoVig_BOS, SurmountFan_IN, PeptideChemSF and 5 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
ZaraB_AL
Member
456
1,678
Jan 2025
Alabama
Dec 2, 2023 at 1:21 AM#29

Want to share my personal experience related to FDA March 2026 enforcement since I think it might help others in a similar situation.

I started my GLP-1 journey in March 2025 at 269 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.

Now, 14 months later: I am down 84 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The FDA March 2026 aspect specifically was something that made a big difference in my journey.

This forum was my go-to resource throughout.

Last edited: Dec 2, 2023 at 2:21 AM
49 7TrialTracker_MD, JennaRN, LabKate and 46 others
Reply Quote Save Share Report
RegAffairsDC
Member
678
3,456
May 2024
Washington, DC
Dec 2, 2023 at 1:38 AM#30

Just wanted to say — for anyone reading this FDA March 2026 thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

Last edited: Dec 2, 2023 at 3:38 AM
32 11gary_naperville, sean_dublin, hannah_MT and 29 others
Reply Quote Save Share Report
14567820

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register